AIM IMMUNOTECH INC's ticker is AIM and the CUSIP is 00901B105. A total of 40 filers reported holding AIM IMMUNOTECH INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $330 | -34.3% | 725 | -3.2% | 0.00% | – |
| Q2 2023 | $502 | +59.4% | 749 | +2.3% | 0.00% | – |
| Q1 2023 | $315 | +38.8% | 732 | +0.7% | 0.00% | – |
| Q4 2022 | $227 | – | 727 | +1.1% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 719 | -93.3% | 0.00% | – |
| Q2 2022 | $8,000 | -27.3% | 10,722 | +4.2% | 0.00% | – |
| Q1 2022 | $11,000 | +10.0% | 10,286 | -12.8% | 0.00% | – |
| Q4 2021 | $10,000 | -54.5% | 11,794 | +9.3% | 0.00% | – |
| Q3 2021 | $22,000 | -4.3% | 10,793 | -0.1% | 0.00% | – |
| Q2 2021 | $23,000 | +155.6% | 10,809 | +187.1% | 0.00% | – |
| Q1 2021 | $9,000 | -87.7% | 3,765 | -90.7% | 0.00% | – |
| Q4 2020 | $73,000 | -20.7% | 40,560 | -5.1% | 0.00% | – |
| Q3 2020 | $92,000 | +1.1% | 42,738 | +15.3% | 0.00% | – |
| Q2 2020 | $91,000 | +2933.3% | 37,078 | +3414.5% | 0.00% | – |
| Q1 2020 | $3,000 | – | 1,055 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ForthRight Wealth Management, LLC | 20,000 | $13,400 | 0.01% |
| SeaCrest Wealth Management, LLC | 37,063 | $24,832 | 0.00% |
| D.B. Root & Company, LLC | 12,050 | $8,074 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 108,900 | $72,963 | 0.00% |
| Traynor Capital Management, Inc. | 11,777 | $7,891 | 0.00% |
| Community Bank, N.A. | 13,226 | $8,861 | 0.00% |
| Verition Fund Management LLC | 140,000 | $93,800 | 0.00% |
| DRW Securities, LLC | 37,000 | $25 | 0.00% |
| SNS Financial Group, LLC | 10,000 | $6,700 | 0.00% |
| HUNTINGTON NATIONAL BANK | 57 | $38 | 0.00% |